Effect of Aripiprazole on Mismatch Negativity (MMN) in Schizophrenia

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Zhou, Zhenhe ^a   Zhu, Hongmei ^a   Chen, Lin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE;

ADULT; ANXIETY; ARTICLE; AUDITORY STIMULATION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; FEMALE; FOLLOW UP; HUMAN; INSOMNIA; MALE; MISMATCH NEGATIVITY; NAUSEA; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; SIDE EFFECT; STIMULUS RESPONSE; TREATMENT DURATION; WAVEFORM;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; COGNITION; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872011135     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052186     Document Type: Article

References (43)

1. Kishi T, Moriwaki M, Kawashima K, Okochi T, Fukuo Y, et al. (2010) Investigation of clinical factors influencing cognitive function in Japanese schizophrenia. Neuroscience Research 66 (4) (): 340-344.
2. Kivircik Akdede BB, Alptekin K, Kitiş A, Arkar H, Akvardar Y, (2005) Effects of quetiapine on cognitive functions in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 29: 233-238.
3. Green MG, Kern RS, Braff DL, Mintz JM, (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the 'right stuff'? Schizophrenia Bull 26 (1) (): 119-136.
4. Evans JD, Bond GR, Meyer PS, Kim HW, Lysaker PH, et al. (2004) Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia. Schizophrenia Research 70: 331-342.
5. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, et al. (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. Journal of Pharmacology and Experimental Therapeutics 302 (1) (): 381-389.
6. Jordan S, Koprivica V, Chen R, Tottori K, Kikuchi T, et al. (2002) The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. European Journal of Pharmacology 441 (3) (): 137-140.
7. Stip E, Tourjman V, (2010) Aripiprazole in schizophrenia and schizoaffective disorder: a review. Clinical Therapeutics (Suppl 1) pp. S3-S20.
8. Kern RS, Green MF, Cornblatt BA, Owen JR, McQuade RD, et al. (2006) The neurocognitive effects of aripiprazole: An open-label comparison with olanzapine. Psychopharmacology 187: 312-320.
9. Riedel M, Spellmann I, Schennach-Wolff R, Musil R, Dehning S, et al. (2010) Effect of aripiprazole on cognition in the treatment of patients with schizophrenia. Pharmacopsychiatry 43 (2) (): 50-57.
10. Murphy A, McKie S, Deakin JFW, (2009) Aripiprazole and risperidone improve working memory in healthy volunteers: an fMRI study. European Neuropsychopharmacology 19: S188-S189.
11. Umbricht DS, Bates JA, Lieberman JA, Kane JM, Javitt DC, (2006) Electrophysiological Indices of Automatic and Controlled Auditory Information Processing in First-Episode, Recent-Onset and Chronic Schizophrenia. Biological Psychiatry 59: 762-772.
12. Naatanen R, (1995) The mismatch negativity: a powerful tool for cognitive neuroscience. Ear and Hearing 16: 6-18.
13. Alain C, Woods DL, (1997) Attention modulates auditory pattern memory as indexed by event-related brain potentials. Psychophysiology 34: 534-546.
14. Dittmann-Balcar A, Thienel R, Schall U, (1999) Attention-dependent allocation of auditory processing resources as measured by mismatch negativity. Neuroreport 10: 3749-3753.
15. Woldorff MG, Hillyard SA, Gallen CC, Hampson SR, Bloom FE, (1998) Magnetoencephalographic recordings demonstrate attentional modulation of mismatch-related neural activity in human auditory cortex. Psychophysiology 35: 283-292.
16. LavoieA S, Murray MM, Deppen P, Knyazeva MG, Berk M, et al. (2007) Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients. Progress in Neuro- Psychopharmacology and Biological Psychiatry 11: 1-13.
17. Tamo N, Patricia TM, William RF, Juanita T, Timothy WB, et al. (2011) Epidural Auditory Event-Related Potentials in the Rat to Frequency and duration Deviants: Evidence of Mismatch Negativity? Frontiers in Psychology 2: 367.
18. Umbricht D, Krljes S, (2005) Mismatch negativity in schizophrenia: a meta-analysis. Schizophrenia Research 76: 1-23.
19. Brockhaus-Dumke A, Tendolkar I, Pukrop R, Schultze-Lutter F, Klosterkötter J, et al. (2005) Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia. Schizophrenia Research 73: 297-310.
20. Javitt DC, Shelley AM, Silipo G, Lieberman JA, (2000) Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. Archives of General Psychiatry 57: 1131-1137.
21. Salisbury DF, Shenton ME, Grigge CB, Bonner-Jackson A, McCarley RW, (2002) Mismatch negativity in chronic schizophrenia and first-episode schizophrenia. Archives of General Psychiatry 59: 686-694.
22. Umbricht D, Koller R, Schmid L, Skrabo A, Grübel C, (2003) How specific are deficits in mismatch negativity generation to schizophrenia? Biological Psychiatry 53: 1120-1131.
23. Yiting L, Min C, Mingjiang L, Chenchung L, Yiling C, et al. (2012) Differentiation of Schizophrenia Patients from Healthy Subjects by Mismatch Negativity and Neuropsychological Tests. PLoS ONE 7 (4) () doi:10.1371/journal.pone.0034454.
24. Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, et al. (2000) Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Archives of General Psychiatry 57: 1139-1147.
25. Lavoie S, Murray MM, Deppen P, Knyazeva MG, Berk M, et al. (2007) Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology 33: 1-13.
26. Kay SR, Fiszbein A, Opler LA, (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bull 13: 261-271.
27. Anneit M, (1970) A classification of hand preference by association analysis. British Journal of Psychiatry 61: 303-321.
28. Zhang MY (1998) Manual for rating scale of psychopathy. 2nd ed. Changsha: Hunan Science Press 150-153.
29. Sato Y, Yabe H, Hiruma T, Sutoh T, Shinozaki N, et al. (2000) The effect of deviant stimulus probability on the human mismatch process. Neuroreport 11: 3703-3708.
30. Yago E, Escera C, Alho K, Giard MH, (2001) Cerebral mechanisms underlying orienting of attention towards auditory frequency changes. Neuroreport 12: 2583-2587.
31. Dittmann BA, Juptner M, Jentzen W, Schall U, (2001) Dorsolateral prefrontal cortex activation during automatic auditory duration-mismatch processing in humans: a positron emission tomography study. Neuroscience Letters 308: 119-122.
32. Michie PT, Innes-Brown H, Todd J, Jablensky AV, (2002) Duration Mismatch Negativity in Biological Relatives of Patients with Schizophrenia Spectrum Disorders. Biological Psychiatry 52: 749-758.
33. Bramon E, Croft RJ, McDonald C, Virdi GK, Gruzelier JG, et al. (2004) Mismatch negativity in schizophrenia: a family study. Schizophrenia Research 67: 1-10.
34. Domján N, Csifcsák G, Drótos G, Janka Z, Szendi I, (2012) Different patterns of auditory information processing deficits in chronic schizophrenia and bipolar disorder with psychotic features. Schizophrenia Research 139: 253-259.
35. Saykin AJ, Gur RC, Gur RE, Mozley PD, Mozley LH, (1991) Neuropsychological function in schizophrenia: selective impairment in memory and learning. Archives of General Psychiatry 48: 618-624.
36. Gold JM, Harvey PD, (1993) Cognitive deficits in schizophrenia. Psychiatric Clinics of North America 16: 295-312.
37. Velligan DI, Mahurin RK, Diamond PL, Hazleton BC, Eckert SL, et al. (1997) The functional significance of symptomatology and cognitive function in schizophrenia. Schizophrenia Research 25: 21-31.
38. Light GA, Braff DL, (2005) Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia. American Journal of Psychiatry 162: 1741-1743.
39. Umbricht D, Javitt D, Novak G, Bates J, Pollack S, et al. (1998) Effects of clozapine on auditory event-related potentials in schizophrenia. Biological Psychiatry 44: 716-725.
40. Umbricht D, Javitt D, Novak G, Bates J, Pollack S, et al. (1999) Effects of risperidone on auditory event-related potentials in schizophrenia. The International Journal of Neuropsychopharmacology 2: 299-304.
41. Korostenskaja M, Dapsys K, Siurkute A, Maciulis V, Ruksenas O, et al. (2005) Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29: 543-548.
42. Hori H, Yoshimura R, Katsuki A, Hayashi K, Ikenouchi-Sugita A, et al. (2012) The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients. Journal of Psychiatric Research 46 (6) (): 757-76.
43. Malhi GS, Lagopoulos J, (2008) Making sense of neuroimaging in psychiatry. Acta Psychiatrica Scandinavica 117: 100-117.